These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8200134)

  • 1. Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats.
    Sagara M; Satoh J; Zhu XP; Takahashi K; Fukuzawa M; Muto G; Muto Y; Toyota T
    Clin Immunol Immunopathol; 1994 Jun; 71(3):333-7. PubMed ID: 8200134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats.
    Tanaka S; Seino H; Satoh J; Fujii N; Rikiishi H; Zhu XP; Takahashi K; Sagara M; Nobunaga T; Toyota T
    Clin Immunol Immunopathol; 1992 Mar; 62(3):258-63. PubMed ID: 1541051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.
    Sagara M; Satoh J; Wada R; Yagihashi S; Takahashi K; Fukuzawa M; Muto G; Muto Y; Toyota T
    Diabetologia; 1996 Mar; 39(3):263-9. PubMed ID: 8721770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production.
    Peristeris P; Clark BD; Gatti S; Faggioni R; Mantovani A; Mengozzi M; Orencole SF; Sironi M; Ghezzi P
    Cell Immunol; 1992 Apr; 140(2):390-9. PubMed ID: 1544168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine attenuates noise-induced permanent hearing loss in diabetic rats.
    Wu HP; Hsu CJ; Cheng TJ; Guo YL
    Hear Res; 2010 Aug; 267(1-2):71-7. PubMed ID: 20430080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine inhibits loss of diaphragm function in streptozotocin-treated rats.
    Hida W; Shindoh C; Satoh J; Sagara M; Kikuchi Y; Toyota T; Shirato K
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1875-9. PubMed ID: 8665049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats.
    Rosa LRO; Kaga AK; Barbanera PO; Queiroz PM; do Carmo NOL; Fernandes AAH
    Can J Physiol Pharmacol; 2018 Apr; 96(4):412-418. PubMed ID: 29378152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation.
    Kamboj SS; Chopra K; Sandhir R
    Neuroscience; 2009 Aug; 162(2):349-58. PubMed ID: 19426784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α, erectile dysfunction, and NADPH oxidase-mediated ROS generation in corpus cavernosum in high-fat diet/streptozotocin-induced diabetic rats.
    Long T; Liu G; Wang Y; Chen Y; Zhang Y; Qin D
    J Sex Med; 2012 Jul; 9(7):1801-14. PubMed ID: 22524530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant N-acetylcysteine attenuates the reduction of Brg1 protein expression in the myocardium of type 1 diabetic rats.
    Xu J; Lei S; Liu Y; Gao X; Irwin MG; Xia ZY; Hei Z; Gan X; Wang T; Xia Z
    J Diabetes Res; 2013; 2013():716219. PubMed ID: 23853776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats.
    Feingold KR; Soued M; Adi S; Staprans I; Shigenaga J; Doerrler W; Moser A; Grunfeld C
    Diabetes; 1990 Dec; 39(12):1569-74. PubMed ID: 1978829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
    Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
    Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
    Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro.
    Cu A; Ye Q; Sarria R; Nakamura S; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):147-54. PubMed ID: 20560295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress.
    Patriarca S; Furfaro AL; Domenicotti C; Odetti P; Cottalasso D; Marinari UM; Pronzato MA; Traverso N
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):48-54. PubMed ID: 15921899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
    Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F
    Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats.
    Fiordaliso F; Bianchi R; Staszewsky L; Cuccovillo I; Doni M; Laragione T; Salio M; Savino C; Melucci S; Santangelo F; Scanziani E; Masson S; Ghezzi P; Latini R
    J Mol Cell Cardiol; 2004 Nov; 37(5):959-68. PubMed ID: 15522273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.